Form 4: Colgate-Palmolive Director Receives Stock Grant & Options

Colgate-Palmolive Director Christopher S. Boerner received an annual stock grant and stock options as part of the company's incentive compensation plan.

Summary

• Christopher S. Boerner, a Director at Colgate-Palmolive Company, was granted 1,383 shares of common stock on May 11, 2026, valued at $0.0000.
• Boerner also received stock options to purchase 2,020 shares of common stock with an exercise price of $86.74, granted on May 11, 2026.
• These options vest in equal annual installments over three years, starting on the first anniversary of the grant date.
• The stock grant is an annual director stock grant under the company's incentive compensation plan.
• The stock options are an annual director stock option grant under the company's incentive compensation plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine director compensation rather than significant financial performance or strategic shifts.

Positives

• Director compensation through stock grants and options aligns with incentive compensation plans, potentially motivating long-term performance.
• The grant of stock and options indicates continued investment in leadership and confidence in future company value.

Future Outlook

The stock options granted have an expiration date of May 11, 2034, and become exercisable in installments over three years, suggesting a long-term outlook for the company's performance.

Industry Context

StockSavvy.ai notes that director compensation packages often include equity awards to align executive interests with shareholder value, a common practice in the consumer staples industry.

Stakeholder Impact

• Shareholders: The compensation structure aligns director interests with long-term shareholder value, potentially leading to better governance and performance.

Next Steps

• Options become exercisable in equal annual installments over three years starting May 11, 2027.

Key Dates

Keywords

Colgate-Palmolive, Form 4, Director Compensation, Stock Grant, Stock Options, Incentive Compensation Plan, Christopher S. Boerner, SEC Filing